6-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereof
US8993576B2 · kind B2 · utility
3Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2011 |
| Grant date | Mar 31, 2015 |
| Priority date | — |
| Expiry date | Oct 25, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a polymorph of a compound and salts of a compound and polymorphs thereof, which compound is an inhibitor of kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.